As an oncogenic lncRNA, SMIM25 has been shown to attenuate mutant-p53-induced ferroptosis and enhance mutant p53-driven proliferation in Glioblastoma Multiforme (GBM) [32]. This evidence concerns the gene TP53 and glioblastoma.